Viking Income Before Tax from 2010 to 2024

VKTX Stock  USD 52.59  0.96  1.86%   
Viking Therapeutics Income Before Tax yearly trend continues to be fairly stable with very little volatility. Income Before Tax is likely to outpace its year average in 2024. During the period from 2010 to 2024, Viking Therapeutics Income Before Tax regression line of annual values had slope of (6,116,296) and arithmetic mean of (30,658,126). View All Fundamentals
 
Income Before Tax  
First Reported
2012-12-31
Previous Quarter
-22.2 M
Current Value
-24.9 M
Quarterly Volatility
7.9 M
 
Yuan Drop
 
Covid
Check Viking Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Viking Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 277.4 K, Interest Expense of 83.6 K or Selling General Administrative of 38.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.29. Viking financial statements analysis is a perfect complement when working with Viking Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Viking Therapeutics Correlation against competitors.
For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.

Latest Viking Therapeutics' Income Before Tax Growth Pattern

Below is the plot of the Income Before Tax of Viking Therapeutics over the last few years. Income Before Tax which can also be referred as pre-tax income is reported on Viking Therapeutics income statement and is an important metric when analyzing Viking Therapeutics profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability. It is Viking Therapeutics' Income Before Tax historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Viking Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Income Before Tax10 Years Trend
Slightly volatile
   Income Before Tax   
       Timeline  

Viking Income Before Tax Regression Statistics

Arithmetic Mean(30,658,126)
Coefficient Of Variation(95.82)
Mean Deviation23,674,216
Median(22,063,000)
Standard Deviation29,377,724
Sample Variance863.1T
Range85.7M
R-Value(0.93)
Mean Square Error123.7T
R-Squared0.87
Slope(6,116,296)
Total Sum of Squares12082.7T

Viking Income Before Tax History

2024-81.6 M
2023-85.9 M
2022-68.9 M
2021-55 M
2020-39.5 M
2019-25.8 M
2018-22.1 M

About Viking Therapeutics Financial Statements

Viking Therapeutics investors use historical fundamental indicators, such as Viking Therapeutics' Income Before Tax, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Viking Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Income Before Tax-85.9 M-81.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Viking Stock Analysis

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.